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Purpose: To evaluate the optic disc characteristics of eyes with superior segmental optic 
hypoplasia (SSOH) using the Heidelberg retina tomograph (HRT).
Patients and methods: Thirteen eyes of 13 Japanese patients with SSOH were studied with 
the HRT (software version: 3.0). The group included six males and seven females, with a mean 
age of 34.7 years. Six optic disc parameters in the six sectors derived from the patients with 
SSOH were compared with those of 13 eyes of 13 normal controls. In addition, the diagnostic 
classification performance of the Frederick S Mikelberg (FSM) discriminant function, glaucoma 
probability score (GPS), and Moorfields regression analysis (MRA) were assessed.
Results: When compared with normal subjects, many of the optic disc parameters were 
significantly altered in SSOH in the superior sectors. The area under the curve (AUC) for 
the receiver operating characteristic was 0.932 for the rim area, 0.926 for the cup-to-disc 
area ratio, and 0.882 for the cup shape measure. Among the HRT parameters, the largest 
AUC (0.988) was found for the cup shape measure in the nasal superior segment. The pro-
portion classified as outside normal limits by the FSM discriminant function was 92.3% (12 
eyes). For GPS, six eyes (46.2%) were classified as outside normal limits. For MRA, when 
borderline cases were considered test-negative or test-positive, 10 eyes (76.9%) or 11 eyes 
(84.6%) were classified as outside normal limits, respectively. The AUCs were 0.976 for the 
FSM discriminant function, 0.914 for the MRA overall classification, and 0.710 for the GPS 
overall classification.
Conclusions: In eyes with SSOH, there is a significant thinning of the rim, especially in the 
nasal superior sector. Approximately half of the eyes with SSOH were classified as abnormal 
using indices developed for detecting glaucoma, but the sectorial analysis revealed that the 
affected sectors were different from those of glaucoma. Optic nerve head measurements using 
the HRT may be useful in evaluating the optic disc characteristics in eyes with SSOH.
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Introduction
Superior segmental optic hypoplasia (SSOH) is a congenital optic nerve anomaly 
characterized by localized inferior visual field defects, superior nerve fiber layer 
defects, and good visual acuity.1–13 The term “superior segmental optic nerve 
hypoplasia” (SSONH), which is preferred by some investigators, has also sometimes 
been used instead of SSOH, because the clinical features of this entity include not 
only a morphologic optic disc anomaly, but also optic nerve fiber defects.10,12 SSOH 
is considered to be a type of optic nerve hypoplasia, but is unusual in that the central 
visual acuity is spared. Kim et al have shown four characteristic findings concerning Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Dovepress
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the optic disc, ie, a relative superior entrance of the central 
retinal artery, a superior peripapillary scleral halo, pallor of 
the superior disc, and a thinning of the superior peripapillary 
nerve fiber layer.4 However, not all of these features could 
be consistently found in other reports.6,8–10 Instead, a double-
ring sign, which is a hallmark of optic hypoplasia, has been 
found.10 Also, while previous reports from Western countries 
have demonstrated that SSOH is frequently associated with 
maternal type 1 diabetes mellitus, reports from Japan and 
Korea have not supported this association.10,12 Thus, the 
definition of SSOH remains obscure, and it may possibly 
consist of multiple optic nerve anomalies.
The Heidelberg retina tomograph (HRT), a confocal 
scanning laser ophthalmoscopy device, has been used to 
evaluate quantitatively the three-dimensional surface topog-
raphy of the optic nerve head and the surrounding nerve 
fiber layer.14–26 HRT can provide objective measurements 
of the optic nerve head, such as the cup-to-disc ratio, cup 
volume, rim area, and thickness of the nerve fiber layer. It 
is well known that glaucomatous visual field defects appear 
only after a substantial number of nerve fibers have been 
lost.27,28 Therefore, HRT is considered to be a promising 
tool for the early detection of glaucoma. A thinning of the 
nerve fiber layer often suggests glaucoma, but SSOH is 
similar to glaucoma in that nerve fiber layer defects and 
corresponding visual field losses are observed.8 In this 
study, we investigated the topography of the optic nerve 
head in SSOH using HRT. This technique includes statis-
tical analyses, Frederick S Mikelberg (FSM) discriminant 
function,14 Moorfields regression analysis (MRA),16 and 
the glaucoma probability score (GPS) classification,18 for 
discriminating glaucomatous and normal optic discs. We 
also used HRT to evaluate the diagnostic ability of these 
tests in patients with SSOH.
Subjects and methods
We examined 13 eyes of 13 patients with SSOH. The mean 
age ± standard deviation of the patients was 34.7 ± 12.9 
(range 15–53) years. There were six males and seven 
females. Seven had bilateral and six had monocular 
SSOH. Only one eye was randomly selected and examined 
for bilateral cases. Each eye had a best-corrected visual 
acuity $20/20 and a normal intraocular pressure (IOP) 
#21 mmHg, with no history of elevated IOP, a normal open 
angle, and an inferior wedge-shaped visual field defect 
(oriented to the blind spot) with a corresponding retinal 
nerve fiber layer defect. The retinal nerve fiber layer defects 
were detected with ophthalmoscopy and documented by 
fundus photographs. None of the patients was born of a 
mother with diabetes mellitus. The average mean devia-
tion of the Humphrey full-threshold 30-2 program was 
−4.35 ± 4.37 (ranging from −11.96 to +1.76) dB. Thirteen 
eyes of 13 subjects with normal vision were also studied 
and served as controls. Only one eye was examined for each 
normal subject. The normal subjects were recruited from 
the hospital staff or their friends. Ophthalmic examination 
of these subjects did not reveal any ocular abnormalities.
In each patient, optic disc topography was examined 
using HRT II (version 3.0; Heidelberg Engineering, GmbH, 
Heidelberg, Germany). Informed consent was obtained from 
each subject. HRT II uses a diode laser (670 nm wavelength) 
to scan the retinal surface sequentially in the horizontal 
and vertical directions on multiple focal planes. By using 
confocal scanning principles, a three-dimensional topo-
graphic image is constructed from a series of optical image 
sections at consecutive focal planes. The topographic 
image determined from the acquired three-dimensional 
image consists of 384 × 384 (147,456) pixels, each of which 
is a measurement of the surface height of retina and optic 
nerve head at its corresponding location. For every subject 
in this study, images were obtained through undilated pupils, 
with a 15° field of view. Three topographic images were 
obtained, combined, and automatically aligned to make 
a single mean topographic image for analysis. A contour 
line of the optic disc margin was drawn around the inner 
margin of the peripapillary scleral ring by an experienced 
examiner, who had been kept uninformed of the other clini-
cal information. Six HRT parameters obtained with routine 
analysis were analyzed in terms of the disc area, cup area, 
cup-to-disc area ratio, rim area, cup shape measure, and 
height variation contour. Magnification errors were corrected 
using the subjects’ refractive status and corneal-curvature 
measurements.
Six sectoral (temporal, nasal, superotemporal, superonasal, 
inferotemporal, and inferonasal) and global optic nerve head 
parameters were compared between those of the control 
subjects and those of patients with SSOH, thus producing 
P values and the area under the curve (AUC for the receiver 
operating characteristic) for each comparison.
For the FSM discriminant function, the discriminant 
analysis formula described by Mikelberg et al was used.14 
We chose the FSM discriminant function because it 
was thought to be the most representative among such 
discriminant functions. In the MRA, a measured rim area Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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was compared with the predicted rim area adjusted for disc 
size and age. The normative database was compared in six 
regions (superior temporal, inferior temporal, temporal, 
superior nasal, inferior nasal, and nasal) and as an overall 
global classification. The eyes were classified into three 
categories: within normal limits (WNL) 95% confidence 
intervals (CI); borderline (BL), 95%–99.9% CI; and outside 
normal limits (ONL), 99.9% CI. In the GPS calculation, 
parameters describing the shape of the optic nerve head 
and retinal nerve fiber layer were calculated based on the 
mathematical model derived from normal and glaucoma-
tous eyes in HRT. The parameters thus obtained were used 
to compute the GPS numeric scores. Then, the final GPS 
was used for the classification was WNL (0%–27%), BL 
(28%–64%), and ONL (65%–100%). The AUC curves were 
plotted between the normal and SSOH eyes for the FSM 
discriminant function, MRA, and GPS. The categoric vari-
able was computed where “normal” = 0, “borderline” = 1, 
and “outside normal limits” = 2.
We used Mann–Whitney’s U test for each comparison. 
Because of the large number of tests, the Bonferroni 
correction for multiple comparisons was also applied. SPSS 
(17.0 J; SPSS Japan, Inc., Tokyo, Japan) and MedCalc (ver-
sion 10.1; MedCalc Software bvba, Mariakerke, Belgium) 
were used to perform the statistical analysis.
Results
Table 1 shows the demographic and clinical characteristics 
of the subjects included in the study. Gender, age, and 
refraction did not differ significantly between the patients 
with SSOH and normal subjects. None of the patients with 
SSOH showed a progression of the visual field defects in the 
subsequent follow-up. The follow-up period was 74.4 ± 27.2 
(range 48–133) months.
Table 2 shows various HRT parameters of the patients 
with SSOH and the healthy control subjects. There was no 
statistically significant difference between the disc area of 
patients with SSOH and normal subjects. The cup area and 
cup-to-disc area ratio were larger, while the rim area was 
reduced, in patients with SSOH, especially in the superonasal 
area. The parameters with the largest AUCs were the nasal 
superior cup shape measure (0.988), the nasal superior cup-
to-disc area ratio (0.970), and the nasal superior rim area 
(0.959). Figure 1 shows the AUC for the nasal superior cup 
shape measure.
The results of the diagnostic classification tests are shown 
in Table 3. Using the FSM discriminant function, 92.3% of 
the eyes were classified as outside the normal limits. By the 
MRA and GPS, 84.6 (*76.9)% and 46.2% of the eyes were 
classified as abnormal, respectively (when the borderline 
was classified as normal). The MRA in each sector revealed 
that the superonasal rim area was most frequently abnormal 
(Figure 2). The AUC was 0.976 for the FSM discriminant 
function, 0.914 for the MRA, and 0.710 for the GPS. The 
sectoral analysis of MRA revealed the largest AUC (0.956) 
in the nasal superior sector. The FSM discriminant function 
showed a sensitivity of 92.3% and a specificity of 92.3%. The 
MRA overall classification had a sensitivity of 84.6 (76.9)% 
and a specificity of 92.3 (100)%. The GPS overall classifi-
cation had a sensitivity of 46.2 (46.2)% and a specificity of 
92.3 (100)%.
Discussion
Our sectorial analysis of the optic nerve head has shown that 
many of the parameters differed significantly between normal 
subjects and patients with SSOH. Also, a large proportion of 
the eyes with SSOH were determined to be abnormal using 
the FSM discriminant function and MRA. It is important to 
distinguish this condition from glaucoma, because costly 
antiglaucoma medication is not warranted in the presence 
of SSOH, assuming that SSOH is a nonprogressive disease. 
Whereas a notch in the inferotemporal or superotemporal rim 
is commonly found in glaucoma, the rim area in the supero-
nasal segment was found by this study to be most decreased 
in cases of SSOH. Our results may be generalized to cases of 
SSOH in general, because it is thought to be a nonprogressive 
disease and the degree of disease severity is not so variable 
as in glaucoma.21,24 There may be “subclinical” SSOH in 
which visual field testing does not detect any abnormality, 
Table 1 Demographic and clinical characteristics of the subjects 
included in the study
SSOH (N = 13)* Normal (N = 13)* P value†
sex (M/F) 6/7 4/9 0.420
Age (years) 34.7 ± 12.9  
(15,53)
34.6 ± 9.1  
(22,55)
0.840
refraction 
(diopters)
−3.71 ± 3.31  
(−10.00, −0.50)
−3.58 ± 1.92  
(−7.25, −1.13)
0.614
MD (dB)‡ −4.35 ± 4.37  
(−11.96, +1.76)
1.26 ± 1.04  
(−0.88, +2.92)
,0.001
Notes: *Data are presented as mean ± standard deviation (range); †P value is for 
comparison between ssOh and normal eyes using Mann–Whitney’s U test; ‡mean 
deviation of Humphrey 30-2 visual field. 
Abbreviations: ssOh, superior segmental optic hypoplasia; M, male; F, female; 
MD, mean deviation.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1196
Miki et al
Table 2 global and segmental optic disc parameters and areas under the receiver operating characteristic curve for each parameter
SSOH (N = 13)* Normal (N = 13)* P value AUC‡
DA global 1.97 ± 0.55 (1.18–3.17) 2.05 ± 0.47 (1.12–2.86) 0.650 0.556 (0.350–0.749)
DA temporal 0.48 ± 0.15 (0.24–0.81) 0.47 ± 0.11 (0.25–0.63) 0.920 0.515 (0.313–0.714)
DA Ts 0.26 ± 0.05 (0.19–0.36) 0.29 ± 0.07 (0.18–0.43) 0.243 0.636 (0.426–0.814)
DA Ti 0.25 ± 0.07 (0.15–0.40) 0.28 ± 0.08 (0.15–0.45) 0.287 0.624 (0.414–0.804)
DA nasal 0.47 ± 0.15 (0.24–0.79) 0.48 ± 0.12 (0.24–0.64) 0.801 0.533 (0.328–0.729)
DA ns 0.25 ± 0.08 (0.14–0.44) 0.26 ± 0.07 (0.13–0.39) 0.579 0.568 (0.361–0.759)
DA ni 0.26 ± 0.06 (0.20–0.39) 0.27 ± 0.06 (0.18–0.37) 0.311 0.621 (0.411–0.802)
CA global 0.93 ± 0.51 (0.29–1.98) 0.40 ± 0.22 (0.03–0.78) 0.007 0.805 (0.603–0.932)
CA temporal 0.28 ± 0.16 (0.08–0.58) 0.19 ± 0.10 (0.02–0.32) 0.153 0.666 (0.455–0.837)
CA Ts 0.14 ± 0.06 (0.05–0.23) 0.06 ± 0.04 (0.00–0.11) ,0.001 0.882 (0.694–0.973)
CA Ti 0.09 ± 0.07 (0.00–0.21) 0.04 ± 0.03 (0.00–0.09) 0.050 0.728 (0.519–0.882)
CA nasal 0.21 ± 0.15 (0.00–0.54) 0.06 ± 0.05 (0.00–0.16) 0.003 0.831 (0.634–0.947)
CA ns 0.15 ± 0.06 (0.02–0.28) 0.04 ± 0.03 (0.00–0.11) ,0.001 0.932 (0.760–0.991)
CA ni 0.07 ± 0.05 (0.00–0.15) 0.02 ± 0.01 (0.00–0.04) 0.002 0.843 (0.648–0.954)
rA global 1.04 ± 0.18 (0.78–1.38) 1.66 ± 0.45 (1.03–2.53) ,0.001 0.932 (0.760–0.991)
rA temporal 0.20 ± 0.05 (0.09–0.30) 0.28 ± 0.11 (0.18–0.52) 0.019 0.769 (0.563–0.910)
rA Ts 0.12 ± 0.03 (0.07–0.18) 0.23 ± 0.07 (0.11–0.33) ,0.001 0.926 (0.752–0.989)
rA Ti 0.16 ± 0.04 (0.09–0.25) 0.24 ± 0.08 (0.14–0.43) 0.002 0.843 (0.648–0.954)
rA nasal 0.26 ± 0.08 (0.10–0.38) 0.42 ± 0.11 (0.21–0.62) ,0.001 0.891 (0.706–0.977)
rA ns 0.10 ± 0.03 (0.04–0.16) 0.22 ± 0.07 (0.13–0.33) ,0.001 0.959 (0.799–0.994)
rA ni 0.20 ± 0.05 (0.14–0.28) 0.26 ± 0.06 (0.18–0.37) 0.006 0.811 (0.610–0.935)
CDAr global 0.45 ± 0.14 (0.23–0.66) 0.19 ± 0.10 (0.01–0.35) ,0.001 0.926 (0.752–0.989)
CDAr temporal 0.55 ± 0.19 (0.24–0.82) 0.40 ± 0.18 (0.06–0.63) 0.072 0.710 (0.500–0.869)
CDAr Ts 0.52 ± 0.15 (0.24–0.78) 0.21 ± 0.15 (0.01–0.47) ,0.001 0.929 (0.756–0.990)
CDAr Ti 0.32 ± 0.21 (0.01–0.67) 0.14 ± 0.11 (0.00–0.27) 0.026 0.754 (0.547–0.900)
CDAr nasal 0.41 ± 0.22 (0.00–0.68) 0.12 ± 0.10 (0.00–0.32) 0.001 0.861 (0.669–0.963)
CDAr ns 0.58 ± 0.14 (0.17–0.74) 0.15 ± 0.12 (0.00–0.43) ,0.001 0.970 (0.817–0.992)
CDAr ni 0.24 ± 0.15 (0.00–0.48) 0.06 ± 0.06 (0.00–0.16) 0.001 0.855 (0.662–0.960)
hVC 0.39 ± 0.13 (0.18–0.68) 0.41 ± 0.07 (0.27–0.52) 0.264 0.633 (0.423–0.811)
hVC temporal 0.15 ± 0.06 (0.04–0.25) 0.20 ± 0.06 (0.12–0.34) 0.101 0.692 (0.482–0.856)
hVC Ts 0.16 ± 0.15 (0.02–0.48) 0.17 ± 0.06 (0.05–0.29) 0.186 0.654 (0.443–0.828)
hVC Ti 0.21 ± 0.08 (0.10–0.38) 0.23 ± 0.09 (0.09–0.38) 0.579 0.568 (0.361–0.759)
hVC nasal 0.14 ± 0.07 (0.06–0.27) 0.11 ± 0.04 (0.06–0.23) 0.479 0.586 (0.378–0.774)
hVC ns 0.09 ± 0.04 (0.03–0.18) 0.05 ± 0.02 (0.03–0.11) 0.019 0.769 (0.563–0.910)
hVC ni 0.09 ± 0.05 (0.02–0.24) 0.07 ± 0.04 (0.02–0.15) 0.186 0.654 (0.443–0.828)
CsM −0.08 ± 0.10 (−0.28–0.11) −0.21 ± 0.05 (−0.28, −0.10) ,0.001 0.882 (0.694–0.973)
CsM temporal −0.07 ± 0.08 (−0.19–0.09) −0.11 ± 0.06 (−0.22, −0.01) 0.113 0.686 (0.476–0.852)
CsM Ts 0.05 ± 0.09 (−0.08–0.25) −0.14 ± 0.12 (−0.31–0.03) ,0.001 0.905 (0.725–0.983)
CsM Ti −0.07 ± 0.14 (−0.37–0.16) −0.22 ± 0.10 (−0.39, −0.07) 0.006 0.811 (0.610–0.935)
CsM nasal −0.00 ± 0.15 (−0.25–0.30) −0.18 ± 0.13 (−0.46, −0.02) 0.005 0.814 (0.613–0.937)
CsM ns 0.15 ± 0.15 (−0.13–0.40) −0.18 ± 0.08 (−0.33, −0.03) ,0.001 0.988 (0.845–1.000)
CsM ni −0.10 ± 0.18 (−0.40–0.18) −0.31 ± 0.15 (−0.55, −0.04) 0.006 0.808 (0.606–0.934)
Notes: *Data are presented as mean ± standard deviation (range); †P value is for comparison of the parameters between ssOh and normal eyes using Mann–Whitney’s 
U test. Because of the multiple comparisons, the Bonferroni correction was applied, with a level of significance of 0.00119. Bold P values are statistically significant. ‡Data are 
expressed with 95% confidence intervals of each value in parentheses. 
Abbreviations: DA, disc area; CA, cup area; rA, rim area; CDAr, cup-to-disc area ratio; hVC, height variation contour; CsM, cup shape measure; Ts, temporal superior; 
Ti, temporal inferior; ns, nasal superior; ni, nasal inferior.
while, in fact, nerve fibers are already reduced. HRT could 
be helpful in such cases.
The definition of SSOH remains to be determined. So 
far, different studies have used different criteria to define 
SOOH. We used diagnostic criteria based on a previous 
report.10 However, the appearances of the optic discs 
of SSOH in this study appear to be somewhat different 
from those reported in Western countries. In general, the 
optic discs of SSOH in Japan often have a glaucoma-like 
cupping.7,8,10 Although glaucoma has to be excluded in the 
initial diagnosis of SSOH, because the former is an acquired 
optic nerve disorder, the association between SSOH and Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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glaucoma remains unclear. It is sometimes difficult to 
differentiate SSOH from glaucoma (especially from nor-
mal-tension glaucoma, in which the IOP is within normal 
limits) because the two share similar optic disc appearance 
features, such as a large cupping and a rim thinning.10 Fur-
thermore, glaucoma and SSOH do coexist in some cases. 
However, optic discs in the case reports from Western 
countries do not seem to show any general glaucoma-like 
cupping.11 Additionally, SSOH is almost never associated 
with maternal diabetes mellitus in Japan. Thus, SSOH may 
be heterogeneous, and our conclusion may apply only to 
the specific type of SSOH that is typically found in Japan 
or Korea. However, superior nerve fiber layer defects and 
corresponding inferior visual field defects (either inferior 
altitudinal defects or inferior sector defects connected to 
the blind spot) are always observed in SSOH.
The visual fields in SSOH are shown to be stable 
over a 10-year period9 or an eight-year period,10 but the 
long-term prognosis is not known, because no longer 
follow-ups have yet been reported. SSOH has been found 
in young patients, in whom glaucoma is less likely than 
in aged patients.10 These findings seem to support the 
notion that SSOH is a congenital anomaly and does not 
progress. HRT could be used for the patients with SSOH 
over time to make sure that there is no progression of 
the disease.
Subjective qualitative techniques, such as ophthalmoscopy, 
are dependent on the examiner’s experience. However, only a 
few previous reports investigating SSOH have utilized objective 
quantitative imaging technologies of the optic disc.7,10,11 Unoki 
et al used OCT to investigate the tomography of the optic disc 
and peripapillary retina in patients with SSOH.7 Using OCT, 
obviously abnormal findings may be observed in patients in 
whom the optic disc shows only minimal changes, even in 
the fundus photograph.7 Although both OCT and HRT can 
provide objective quantitative measurements of optic disc 
topography, the fundamental measurement principles of these 
two instruments are different. HRT is thought to be specifically 
useful for accurate structural assessments of the optic nerve 
head.16,19 A recent study utilizing OCT and HRT in SSOH 
generally supports our findings.13
In this study, most eyes with SSOH were classified as 
abnormal, with a high specificity, using the FSM discriminant 
function and MRA. HRT generally requires a manual draw-
ing of the contour line of the edge of the optic disc,16,19 and 
this process introduces an element of uncontrolled variabil-
ity into the analysis because such contour lines, drawn by 
different observers, may vary considerably. The outlining 
of the disc margin is not necessary for GPS, and thus GPS 
is considered to be a more objective method than MRA.18 
While sensitivity and specificity values were found to be 
comparable between MRA and GPS in some reports,20 the 
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agreement between MRA and GPS is not necessarily high 
in defining glaucoma in other reports.22 This study also 
shows that such an agreement is not high in SSOH either, 
probably reflecting the differences in the analysis algorithm. 
It is not surprising to find a rather low sensitivity for the 
GPS, because this is a diagnostic test designed specifically 
for glaucoma,18 but not for SSOH. Alternatively, the GPS 
results in this study may have revealed that the GPS is not 
sensitive to the local rim-volume losses, which are shown 
by MRA, because of the influence of neighboring normal 
sectors.20 Therefore, sectorial HRT-GPS analysis appears 
to have some limitations, although it has the clear merit 
that it is independent of the contour line traced manually 
by an examiner. Although it has been reported that both 
GPS and MRA are likely to produce many false-positive 
Table 3 ROC, sensitivity, and specificity for the FSM discriminant function, MRA, and GPS used to discriminate between normal eyes 
and eyes with ssOh
ROC Sensitivity Specificity
FsM 0.976 (0.826–0.990) 92.3 (63.9–98.7)% 92.3 (63.9–98.7)%
MrA overall 0.914 (0.736–0.986) BL = abnormal 84.6 (54.5–97.6)% 92.3 (63.9–98.7)%
BL = normal 76.9 (46.2–94.7)% 100 (75.1–100)%
MrA global 0.885 (0.698–0.974) BL = abnormal 76.9 (46.2–94.7)% 100 (75.1–100)%
BL = normal 76.9 (46.2–94.7)% 100 (75.1–100)%
MrA temporal 0.538 (0.334–0.734) BL = abnormal 7.7 (1.3–36.1)% 100 (75.1–100)%
BL = normal 0.0 (0.0–24.9)% 100 (75.1–100)%
MrA temporal superior 0.654 (0.443–0.828) BL = abnormal 30.8 (9.3–61.4)% 100 (75.1–100)%
BL = normal 30.8 (9.3–61.4)% 100 (75.1–100)%
MrA temporal inferior 0.615 (0.406–0.797) BL = abnormal 23.1 (5.3–53.8)% 100 (75.1–100)%
BL = normal 23.1 (5.3–53.8)% 100 (75.1–100)%
MrA nasal 0.846 (0.651–0.955) BL = abnormal 69.2 (38.6–90.7)% 100 (75.1–100)%
BL = normal 69.2 (38.6–90.7)% 100 (75.1–100)%
MrA nasal superior 0.956 (0.794–0.994) BL = abnormal 92.3 (63.9–98.7)% 92.3 (63.9–98.7)%
BL = normal 84.6 (54.5–97.6)% 100 (75.1–100)%
MrA nasal inferior 0.654 (0.443–0.828) BL = abnormal 30.8 (9.3–61.4)% 100 (75.1–100)%
BL = normal 30.8 (9.3–61.4)% 100 (75.1–100)%
gPs overall 0.710 (0.500–0.869) BL = abnormal 46.2 (19.3–74.8)% 92.3 (63.9–98.7)%
BL = normal 46.2 (19.3–74.8)% 100 (75.1–100)%
gPs global 0.731 (0.522–0.884) BL = abnormal 46.2 (19.3–74.8)% 100 (75.1–100)%
BL = normal 46.2 (19.3–74.8)% 100 (75.1–100)%
gPs temporal 0.727 (0.509–0.886) BL = abnormal 45.5 (16.9–76.5)% 100 (75.1–100)%
BL = normal 45.5 (16.9–76.5)% 100 (75.1–100)%
gPs temporal superior 0.706 (0.48–0.872) BL = abnormal 45.5 (16.9–76.5)% 92.3 (63.9–98.7)%
BL = normal 45.5 (16.9–76.5)% 100 (75.1–100)%
gPs temporal inferior 0.727 (0.509–0.886) BL = abnormal 45.5 (16.9–76.5)% 100 (75.1–100)%
BL = normal 45.5 (16.9–76.5)% 100 (75.1–100)%
gPs nasal 0.727 (0.509–0.886) BL = abnormal 45.5 (16.9–76.5)% 100 (75.1–100)%
BL = normal 45.5 (16.9–76.5)% 100 (75.1–100)%
gPs nasal superior 0.727 (0.509–0.886) BL = abnormal 45.5 (16.9–76.5)% 100 (75.1–100)%
BL = normal 45.5 (16.9–76.5)% 100 (75.1–100)%
gPs nasal inferior 0.727 (0.509–0.886) BL = abnormal 45.5 (16.9–76.5)% 100 (75.1–100)%
BL = normal 45.5 (16.9–76.5)% 100 (75.1–100)%
Note: Data are expressed with 95% confidence intervals of each value in the parentheses. 
Abbreviations: FSM, FSM classification; MRA, Moorfield regression analysis; GPS, glaucoma probability score; “BL = abnormal”, when the borderline is regarded as abnormal; 
“BL = normal”, when the borderline is regarded as normal; rOC, receiver operating characteristic; ssOh; superior segmental optic hypoplasia.
classifications in glaucoma,20 high specificity values were 
obtained in SSOH. It has been reported that optic disc size 
influences the diagnostic accuracy of HRT in glaucoma, 
with small optic discs showing a lower sensitivity and a 
higher specificity compared with larger discs.24 In this study, 
the disc area in SSOH was not statistically significantly 
different from that of the controls.
Since diagnostic tests for glaucoma using HRT frequently 
determine the SSOH to be abnormal, it will be necessary in a 
future study to develop a test which can reliably differentiate 
SSOH from glaucoma. From our results, it seems that HRT 
can discern the pattern of the area of rim losses between 
SSOH and glaucoma. Our results also indicate that HRT can 
be useful in identifying a reduction of the rim area, especially 
in the superonasal region, in patients with SSOH.Clinical Ophthalmology
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